Aerpio
is an Ohio-based biopharmaceutical company that develops and commercializes Tie2-based protein therapeutics for the treatment of ocular diseases... Read moreAerpio
is an Ohio-based biopharmaceutical company that develops and commercializes Tie2-based protein therapeutics for the treatment of ocular diseases... Read more
News
Aug 27, 2021
Citybizlist
Aerpio: Aadi Bioscience Closes Merger with Aerpio Pharmaceuticals
Aug 25, 2021
The Business Journals: Cincinnati Business Courier
Aerpio: Greater Cincinnati public company inks six-figure deal as merger looms
Aug 24, 2021
MarketScreener
Aerpio: Aerpio Pharmaceuticals : ASSET PURCHASE AGREEMENT (Form 8-K)
Jun 11, 2021
Virtual-Strategy Magazine
Aerpio: Lifshitz Law Firm, P.C. Announces Investigation of ARPO, CNBKA, CHAQ, DSSI, INSW, FORE, FTIV, ONB, FMBI, and GRA
Jun 10, 2021
MarketScreener
Aerpio: SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of ARPO, CORE, UFS, and EQT Mergers
Jun 08, 2021
MarketScreener
Aerpio: SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ARPO, ALTA, MMAC, SBBP; Shareholders are Encouraged to Contact the Firm
Jun 04, 2021
MarketScreener
Aerpio: Aerpio Provides Second Update on Aadi Bioscience Presentation at the ASCO 2021 Virtual Meeting
May 27, 2021
Benzinga
Aerpio: SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Aerpio Pharmaceuticals, Inc. Merger
May 27, 2021
Benzinga
Aerpio: AERPIO ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ARPO and Encourages Investors to Contact the Firm
May 22, 2021
MarketScreener
Aerpio: SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Aerpio Pharmaceuticals, Inc. - ARPO
Aerpio Competitors
1
2
3
4
5
6
7
8
9
10